DOX241220P90000
- 5.93
- 0.000.00%
Amdocs Newsroom
Amdocs Management to Meet Virtually With Benchmark
S&P 500 Futures Climb In Premarket Trading; Bath & Body Works, Rocket Lab USA Lead
Amdocs' (NASDAQ:DOX) Investors Will Be Pleased With Their Notable 37% Return Over the Last Five Years
We Think You Can Look Beyond Amdocs' (NASDAQ:DOX) Lackluster Earnings
A Quick Look at Today's Ratings for Amdocs(DOX.US), With a Forecast Between $100 to $111
Amdocs Price Target Lowered to $111 From $113 at Barclays
Amdocs: Hold Rating Maintained Amidst Strategic Restructuring and Modest Growth Prospects
Top Gap Ups and Downs on Wednesday: SPOT, RIVN, STM and More
Amdocs | 6-K: Report of foreign private issuer (related to financial reporting)
Unusual Options Activity: GAP, SQ and Others Attract Market Bets, GAP V/OI Ratio Reaches 468.8
Amdocs Is Maintained at Outperform by Oppenheimer
Amdocs Analyst Ratings
S&P 500 Futures Drop In Premarket Trading; Rocket Lab USA, CAVA Group Lead
The Consensus EPS Estimates For Amdocs Limited (NASDAQ:DOX) Just Fell Dramatically
BofA Securities Maintains Amdocs(DOX.US) With Buy Rating, Announces Target Price $100
Amdocs's Strategic Shift to Cloud Solutions and Operational Efficiency Drives Buy Rating
Express News | Amdocs Ltd : Oppenheimer Raises Target Price to $105 From $98
Amdocs Limited Reports Record Revenue for Fiscal 2024
Express News | Amdocs Shares Are Trading Lower After the Company Reported Worse-than-expected Q4 Revenue Results
Amdocs (DOX) Q4 Earnings Match Estimates